fashion -WSS

fashion

author：knowledge 2025-09-28 09:11:49 - browse：6

Scientist walks up a strand of DNA -- First Opinion coverage from STAT — Adobe

Eli Lilly said Tuesday that it will pay $200 million to gene-editing firm Beam Therapeutics for Beam’s stake in Verve Therapeutics, another gene-editing company focused on treatments for heart disease.

The deal, which also includes future milestone payments, is evidence that despite the pressure on biotechnology stocks there is still interest in very early cutting-edge technologies among big pharmaceutical players. It also provides Beam, which announced on Oct. 19 that it would cut 100 jobs, or 20% of its workforce, to save cash, a large infusion of money.

“This is like a true win-win-win deal, which is rare in this business, but it’s really, really exciting to see,” said John Evans, Beam’s CEO, in an interview with STAT.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Morphosys mixed study results for blood cancer drug

WSS

Antibiotic resistance nearly killed me, so I'm raising awareness of it

Morphosys mixed study results for blood cancer drug

Heat waves linked to early deliveries, preterm births in new study

Prosthetic arm enables patients to feel the objects they grip

David Sabatini, ex

Childhood cancer progress stalls for Black, Hispanic kids: Report

Wikipedia

fashion

entertainment

Hepatitis C has a cure — but many Americans still lack access to it

Does good food count as health care? Study aims to find out

23andMe had bad news about my health. I wish a person had delivered it

Readout Newsletter: Bayer study halts, Carmot to IPO, and more

Guidelines to prevent youth baseball injuries need more muscle

Does good food count as health care? Study aims to find out

Affirmative action in medical school literally saved lives

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Childhood cancer progress stalls for Black, Hispanic kids: Report

focus

Wegovy, Zepbound and weight loss drugs that preserve muscle

Akili, maker of video game for ADHD, to be acquired for 34 million

Readout Newsletter: Insmed, Asahi Kasei, Agios, Royalty Pharma

Average age of first period drops to 11.9 years, study shows

Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

focus

hotspot

Wikipedia

entertainment